3 Stocks That Turned $1,000 Into $1 Million (or More) In all three cases it started with a must-have product or service that's easy and affordable enough to buy over and over again.
Sandisk Stock Is Up 1,500% in the Past Year Due to AI -- Is It Still a Buy? Wall Street Has a Surprising Answer for Investors. Sandisk stock increased 16x in the past year as demand for artificial intelligence infrastructure led to a severe supply shortage in memory chips and storage devices.
Economic Data Forecasts For The Weeks Of Feb. 2 And 9 Expectations for economic data releases coming up in the first half of February.
Market At Risk Of Correcting In A 'Risk-Off' Reset? Stocks have been stuck in a compressing trading range for the past several months.
The AI Stock Wall Street Insiders Are Quietly Buying Billionaires are buying this maker of critical mapping and positioning software at a discount.
CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026 The CEO of this leading medical diagnostic company sold shares throughout multiple days in January. But the manner in which the shares were sold shouldn't concern investors.
Elon Musk Says 'Saving The State' As Delaware Supreme Court Slashes Tesla Legal Fees By Over $100 Million The Delaware Supreme Court cut Tesla's shareholder lawsuit legal fees to $70.9M while upholding a $919M director compensation settlement.
Could Royal Caribbean and Six Flags Be Lifelong Leisure Stocks for Your Portfolio? Leisure stocks can provide good returns, if you can ride out the waves during economic downturns.
Harmony Biosciences Chief Financial Officer Sells Shares Again After Previous Exit From Company Equity This top executive at Harmony Biosciences previous sold all of his direct shares in the company in early January 2026. But towards the end of the month, some options and restricted stock units vested, and everything changed.
Trump Confident In Bipartisan Support For Fed Chair Nominee Kevin Warsh President Donald Trump expressed confidence that his Fed nominee, Kevin Warsh, could win bipartisan Senate support.
Scholar Rock Chief Scientific Officer Conducts Multiple Sales Throughout January 2026 The Chief Scientific Officer of Scholar Rock Holding Corp has made multiple filings regarding disposals in January 2026, but this should not alarm investors.
Ford, Xiaomi Deny JV Talks Even As Jim Farley Expressed Admiration For Chinese EVs While Flagging Them As Competitive Threat Ford reportedly had preliminary discussions with Xiaomi about a joint venture, aiming to facilitate Chinese carmakers' entry into the U.S. market.
3 Questions Investors Should Answer Before Buying Beyond Meat Stock Beyond Meat was a market darling when it first went public, but you'll want to tread cautiously if you are looking to buy it today.
Trump Limits DHS Intervention In Protests To Local Requests, Says Will Not Participate In Any Circumstance 'Until…' Trump announced Homeland Security will only intervene in Dem cities' protests if asked, while Fed buildings will be protected as backup.
Tesla Rival Waymo Targets $16 Billion Funding Round, Valuation Nears $110 Billion: Report Despite recent safety concerns, Waymo continues to expand operations and faces potential impact on industry.
Large Biotech Fund Sells Shares of Cogent Biosciences for Over $120M A large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual performance ever in 2025.
Should You Buy Nio Stock While It's Below $5 a Share? Nio is an innovative auto company operating in the world's largest auto market, but I'm still bearish on it.
Pete Buttigieg Says Trump 'Failed To Bring Down Prices,' Warns Affordability Crisis Is Hitting American Families Transportation Secretary Pete Buttigieg criticized Trump administration and Republicans for rising costs, stalled healthcare relief.
Enliven Therapeutics Chief Scientific Officer Sells ELVN 20K Shares Worth Over $500k The Chief Scientific Officer of this biopharmaceutical company sold 20,000 shares in mid-January 2026, amid the company's stock rising 71% throughout the month.
Protagonist Therapeutics Chief Medical Officer Sells PTGX 9,514 Shares for $784K to Cover Taxes The chief medical officer at one of the top pharmaceutical companies sold nearly 10,000 shares in late January 2026, but the reason was for something very simple.
1 Underrated Reason Netflix's Growth Story Isn't Over The streaming giant's stock is trading at much lower levels than it was a year ago.
Amylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 Million A Co-CEO of a leading neurotherapeutics developer reported significant insider selling amid a year of standout stock performance. But the sale is not what it seems.
4 Ways to Set Your 401(k) Up for Success in 2026 With the right strategy, you can grow your savings nicely this year.
Investment Firm Bouvel Raised Its Stake in This ETF by $8 Million. Is It a Buy? This actively managed fixed income ETF targets diversified bond exposure and reported a 5.09% annualized yield in its latest filing.
San Jose Mayor Matt Mahan Joins Crowded California Governor's Race San Jose Mayor Matt Mahan announced his run for California governor, citing his wife's encouragement, pledging major reforms.
Import Trends: Output, Policy Uncertainty, And/Or Tariffs The slowing of the economy (as measured by domestic final sales) and the increase in the contemporaneous tariff rate have roughly equal coefficients.
Harmony Biosciences' CFO Sells All of His Insider Shares, Worth $752,800 This bioscience company has had promising financials, yet one of its top executives exited his entire direct equity ownership in mid-January 2026.
Harmony Biosciences' CFO Sells All of Her Insider Shares, Worth $752,800 This bioscience company has had promising financials, yet one of its top executives exited her entire direct equity ownership in mid-January 2026.
2 Financial Stocks Poised for a Comeback in 2026 The sell-off in Mastercard and Visa is a tremendous buying opportunity for long-term investors.
2 High-Flying Electric Vehicle Stocks Have Serious Momentum -- But Are They Buys? These two EV stocks are hot topics in the automotive industry, but only one is a buy for risk-tolerant investors.
Arcellx Director Sells 6,000 Shares for $450,000 A director at one of the top clinical-stage biotech companies sold 6,000 insider shares towards the end of January 2026 amid the company's stock having an underwhelming performance in 2025.
Is This Fixed Income ETF a Buy After Symmetry Partners Initiated a Large Position Valued at Nearly $134 Million? The Dimensional Global Core Plus Fixed Income ETF offers access to global bonds spanning government, corporate, and securitized markets.
NXP Semiconductors (NXPI) Q4 Earnings Report Preview: What To Look For Chip manufacturer NXP Semiconductors (
NASDAQ: NXPI )
will be announcing earnings results this Monday after market hours. Here’s what to look for.
Earnings To Watch: Capital Southwest (CSWC) Reports Q4 Results Tomorrow Business development company Capital Southwest (
NASDAQ:CSWC ) will be announcing earnings results this Monday after market close. Here’s what investors should know.
Tyson Foods Earnings: What To Look For From TSN Meat company Tyson Foods (
NYSE:TSN )
will be reporting results this Monday morning. Here’s what you need to know.
MGIC Investment (MTG) To Report Earnings Tomorrow: Here Is What To Expect Mortgage insurer MGIC Investment (
NYSE:MTG ) will be reporting earnings this Monday afternoon. Here’s what investors should know.
What To Expect From Teradyne’s (TER) Q4 Earnings Semiconductor testing company Teradyne (
NASDAQ:TER ) will be announcing earnings results this Monday after market hours. Here’s what to expect.
What To Expect From Woodward’s (WWD) Q4 Earnings Aerospace and defense company Woodward (
NASDAQ:WWD ) will be announcing earnings results this Monday afternoon. Here’s what to look for.
Palantir Technologies (PLTR) Reports Earnings Tomorrow: What To Expect Data analytics company Palantir Technologies (
NASDAQ:PLTR ) will be reporting results this Monday after market close. Here’s what you need to know.
